Atherectomy in complex infrainguinal lesions: A review

Journal of Cardiovascular Surgery

Volumn 56, Issue 1, 2015, Pages 43-54

  Engelberger, S ^a   Van Den Berg Jc, J C ^a  

^a REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

Atherectomy; Coronary restenosis; Cular procedures; Endovas

Indexed keywords

ARTERY CALCIFICATION; ARTERY LESION; ATHERECTOMY; COMPLEX FEMOROPOPLITEAL LESION; DIRECT ATHERECTOMY; DIRECTIONAL ATHERECTOMY; EXCIMER LASER; HUMAN; IN-STENT RESTENOSIS; LASER ATHERECTOMY; ORBITAL ATHERECTOMY; ORBITAL ATHERECTOMY DEVICE; POPLITEAL ARTERY; REVIEW; ROTATIONAL ATHERECTOMY; SILVERHAWK; ADVERSE EFFECTS; CONSTRICTION, PATHOLOGIC; DEVICE FAILURE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; INGUINAL CANAL; PATHOLOGY; PERIPHERAL VASCULAR DISEASES; PROCEDURES; SEVERITY OF ILLNESS INDEX; STENT; THERAPEUTIC USE; TREATMENT OUTCOME; VASCULAR CALCIFICATION; VASCULAR PATENCY;

ALLOY; NITINOL;

ALLOYS; ATHERECTOMY; CONSTRICTION, PATHOLOGIC; EQUIPMENT FAILURE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; INGUINAL CANAL; LASERS, EXCIMER; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME; VASCULAR CALCIFICATION; VASCULAR PATENCY;

EID: 84926178275     PISSN: 00219509     EISSN: 1827191X     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley C V, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
2. Hooi JD, Kester a D, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus JA. Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol 2001;153:666-72.
3. Surgeon V, Street P. Critical limb ischaemia: management and outcome. Report of a national survey. Eur J Vasc Endovasc Surg 1995;113:108-13.
4. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes F G R, Gillespie I et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010;51(5 Suppl):5S-17S.
5. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 1995;274:165-71.
6. Norgren L, Hiatt WR, Dormandy J a, Nehler MR, Harris K a, Fowkes F G R. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Tasc II):S5-67.
7. Dorrucci V. Treatment of superficial femoral artery occlusive disease. J Cardiovasc Surg (Torino) 2004;45:193-201.
8. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991;83(2 Suppl):I70-I80.
9. Buckley CJ, Arko FR, Lee S, Mettauer M, Little D, Atkins M etal. Intravascular ultrasound scanning improves long-term patency of iliac lesions treated with balloon angioplasty and primary stenting. J Vasc Surg 2002;35:316-23.
10. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-9.
11. Chowdhury MM, McLain AD, Twine CT. Angioplasty versus bare metal stenting for superficial femoral artery lesions (Review). Cochrane database Syst Rev 2014; CD006767.
12. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5.
13. Schlager O, Dick P, Sabeti S, Amighi J, Mlekusch W, Minar E et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 2005;12:676-84.
14. Dahl J, Dietz U, Haager PK, Silber S, Niccoli L, Buettner J et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 2002;105:583-8.
15. Vroegindeweij D, Tielbeek a V, Buth J, Schol FP, Hop WC, Landman GH. Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year followup with color-flow duplex scanning. J Vasc Surg 1995;21:255-68.
16. Simonton C A., Leon MB, Bairn DS, Hinohara T, Kent KM, Bersin RM et al. 'Optimal' directional coronary atherectomy: Final results of the optimal atherectomy restenosis study (OARS). Circulation 1998;97:332-9.
17. Baim DS, Cutlip DE, Sharma SK, Ho K K L, Fortuna R, Schreiber TL et al. Final results of the balloon vs optimal atherectomy trial (BOAT). Circulation 1998;97:322-31.
18. Topol E, Leya F. A comparison of directional atherectomy with coronary angioplsty in patients with coronary artery disease. The CAVEAT Study Group. New Engl J Med 1993;329:221-7.
19. Zeller T, Rastan A, Schwarzwalder U, Frank U, Burgelin K, Amantea P et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: sixmonth results from a single-center experience. J Endovasc Ther 2004;11:676-85.
20. Zeller T, Rastan A, Sixt S, Schwarzwalder U, Schwarz T, Frank U et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006;48:1573-8.
21. Ramaiah V, Gammon R, Kiesz S, Cardenas J, Runyon JP, Fail P et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther 2006;13:592-602.
22. McKinsey JF, Zeller T, Rocha-singh KJ, Do M R J, Garcia LA, Investigators D L E. Lower Extremity Revascularization Using Directional Atherectomy. JACC Cardiovasc Interv 2014;7:923-33.
23. Shammas NW, Dippel EJ, Coiner D, Shammas G a, Jerin M, Kumar A. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther 2008;15:270-6.
24. Roberts D, Niazi K, Miller W, Krishnan P, Gammon R, Schreiber T et al. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca++ trial. Catheter Cardiovasc Interv 2014;84:236-44.
25. Keeling WB, Shames ML, Stone P a, Armstrong P a, Johnson BL, Back MR et al. Plaque excision with the Silverhawk catheter: early results in patients with claudication or critical limb ischemia. J Vasc Surg 2007;45:25-31.
26. Sixt S, Carpio Cancino OG, Treszl A, Beschomer U, Macharzina R, Rastan A et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg 2013;58:682-6.
27. Cioppa A, Stabile E, Popusoi G, Salemme L, Cota L, Pucciarelli A et al. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results. Cardiovasc Revascularization Med 2012;13:219-23.
28. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelvemonth Zilver PTX randomized study results. Circ Cardiovasc Interv 2011;4:495-504.
29. ® single arm study: 12-Month results from the TASC C/D lesion subgroup. J Cardiovasc Surg (Torino) 2013;54:115-22.
30. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-76.
31. Micari A, Cioppa A, Vadalà G, Castriota F, Liso A, Marchese A et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. JACC Cardiovasc Interv 2012;5:331-8.
32. Safian RD, Niazi K, Runyon JP, Dulas D, Weinstock B, Ramaiah V et al. Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv 2009;73:406-12.
33. Dattilo R, Himmelstein SI, Cuff RE The COMPLIANCE 360° Trial: A randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol 2014;26:355-60.
34. Shammas NW, Lam R, Mustapha J, Ellichman J, Aggarwala G, Rivera E et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther 2012;19:480-8.
35. Das T, Mustapha J, Indes J, Vorhies R, Beasley R, Doshi N etal. Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry. Catheter Cardiovasc Interv 2014;83:115-22.
36. Staniloae CS, Korabathina R, Lane T a, Dattilo R, Church KJ, Mody KP et al. Study to determine the clinical significance of hemolysis during orbital atherectomy (CLEAR study). J Endovasc Ther 2011;18:57-63.
37. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi J et al. Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg. New Engl J Med 2008;358:689-99.
38. Werk M, Langner S, Reinkensmeier B, Boettcher H-F, Tepe G, Dietz U et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008;118:1358-65.
39. Scheinert D, Laird JR, Schroder M, Steinkamp H, Balzer JO, Biamino G. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther 2001;8:156-66.
40. Laird JR, Zeller T, Gray BH, Scheinert D, Vranic M, Reiser C et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 2006;13:1-11.
41. Fernandez N, McEnaney R, Marone LK, Rhee RY, Leers S, Makaroun M et al. Predictors of failure and success of tibial interventions for critical limb ischemia. J Vasc Surg 2010;52:834-42.
42. Sultan S, Tawfick W, Hynes N. Cool excimer laser-assisted angioplasty (CELA) and tibial balloon angioplasty (TBA) in management of infragenicular arterial occlusion in critical lower limb ischemia (CLI). Vasc Endovascular Surg 2013;47:179-91.
43. Wissgott C, Kamusella P, Ludtke C, Andresen R. Excimer laser atherectomy after unsuccessful angioplasty of TASC C and D lesions in femoropopliteal arteries. J Cardiovasc Surg (Torino) 2013;54:359-65.
44. Schmidt A, Zeller T, Sievert H, Krankenberg H, Torsello G, Stark Ma et al. Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study. J Endovasc Ther 2014;21:52-60.
45. Farb A, Kolodgie FD, Hwang J-Y, Burke AP, Tefera K, Weber DK et al. Extracellular matrix changes in stented human coronary arteries. Circulation 2004;110:940-7.
46. Dick P, Mlekusch W, Schlager O, Amighi J, Haumer M, Cejna M et al. Angioplasty versus Peripheral Cutting Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Initial Experience. Radiology 2008;248:297-302.
47. Van den Berg JC, Pedrotti M, Canevascini R, Chevili SC. In-Stent Restenosis: Mid-Term Results of Debulking Using Excimer Laser and Drug-Eluting Balloons: Sustained Benefit ? J Invasive Cardiol 2014;26:333-7.
48. Stabile E, Virga V, Salemme L, Cioppa A, Ambrosini V, Sorropago G et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012;60(18):1739-42.
49. Gandini R, Del Giudice C, Merolla S, Morosetti D, Pampana E, Simonetti G. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther 2013;20:805-14.
50. Zeller T, Krankenberg H, Steinkamp H, Rastan A, Sixt S, Schmidt A et al. One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD Trial. J Endovasc Ther 2009;16:653-62.
51. Beschomer U, Krankenberg H, Scheinert D, Sievert H, Tübler T, Sixt S et al. Rotational and aspiration atherectomy for infrainguinal in-stent restenosis. Vasa 2013;42:127-33.
52. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte K-L et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007;116:285-92.
53. Vroegindeweij D, Kemper FJ, Tielbeek AV, Buth J, Landman G. Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. Eur J Vasc Surg 1992;164-71.
54. Medica EM, Diamantopoulos A, Katsanos K. Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Surg (Torino) 2014;10.